Plasma nortriptyline and clinical response–a study using changing plasma levels
Graham D. Burrows, Kay P. Maguire, Bruce A. Scoggins, James Stevenson, Brian Davies
Abstract
Graham D. Burrows, Kay P. Maguire, Bruce A. Scoggins, James Stevenson, Brian Davies
Abstract
In a 5-week study of 22 depressed patients treated with nortriptyline, significant changes in plasma levels, both elevated and reduced, were deliberately produced in the third and fourth weeks of each patient's treatment. Correlation of plasma nortriptyline levels and changes in the severity of depression, as measured by the Hamilton Depression Scale, showed no significant relationships. The implications of the study are discussed.
OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In a 5-week study of 22 depressed patients treated with nortriptyline, significant changes in plasma levels, both elevated and reduced, were deliberately produced in the third and fourth weeks of each patient's treatment. Correlation of plasma nortriptyline levels and changes in the severity of depression, as measured by the Hamilton Depression Scale, showed no significant relationships. The implications of the study are discussed.
Key concepts: Nortriptyline, Plasma levels, Depression (economics), Internal medicine, Plasma concentration, Medicine, Psychology, Clinical psychology